RenovoRx Inc (RNXT)
1.243
+0.03
(+2.73%)
USD |
NASDAQ |
Apr 26, 16:00
1.28
+0.04
(+2.98%)
Pre-Market: 20:00
RenovoRx Price: 1.243 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 1.21 | 1.38 | 1.21 | 1.243 | 27483.00 |
Apr 25, 2024 | 1.235 | 1.250 | 1.21 | 1.21 | 3465.00 |
Apr 24, 2024 | 1.22 | 1.23 | 1.19 | 1.213 | 3615.00 |
Apr 23, 2024 | 1.19 | 1.21 | 1.170 | 1.20 | 2941.00 |
Apr 22, 2024 | 1.17 | 1.280 | 1.160 | 1.23 | 4385.00 |
Apr 19, 2024 | 1.23 | 1.250 | 1.16 | 1.17 | 20059.00 |
Apr 18, 2024 | 1.290 | 1.290 | 1.15 | 1.22 | 5264.00 |
Apr 17, 2024 | 1.10 | 1.200 | 1.10 | 1.19 | 7297.00 |
Apr 16, 2024 | 1.14 | 1.23 | 1.12 | 1.130 | 21215.00 |
Apr 15, 2024 | 1.28 | 1.28 | 1.15 | 1.15 | 30352.00 |
Apr 12, 2024 | 1.33 | 1.33 | 1.22 | 1.22 | 10886.00 |
Apr 11, 2024 | 1.214 | 1.358 | 1.185 | 1.29 | 52986.00 |
Apr 10, 2024 | 1.125 | 1.236 | 1.125 | 1.196 | 18296.00 |
Apr 09, 2024 | 1.15 | 1.23 | 1.12 | 1.18 | 69456.00 |
Apr 08, 2024 | 1.15 | 1.56 | 1.12 | 1.17 | 900837.0 |
Apr 05, 2024 | 1.30 | 1.35 | 1.13 | 1.155 | 23645.00 |
Apr 04, 2024 | 1.33 | 1.33 | 1.195 | 1.20 | 15713.00 |
Apr 03, 2024 | 1.241 | 1.298 | 1.215 | 1.26 | 10484.00 |
Apr 02, 2024 | 1.31 | 1.31 | 1.18 | 1.24 | 26464.00 |
Apr 01, 2024 | 1.30 | 1.38 | 1.30 | 1.32 | 13527.00 |
Mar 28, 2024 | 1.316 | 1.40 | 1.25 | 1.34 | 17338.00 |
Mar 27, 2024 | 1.39 | 1.42 | 1.30 | 1.38 | 19101.00 |
Mar 26, 2024 | 1.33 | 1.506 | 1.30 | 1.30 | 10681.00 |
Mar 25, 2024 | 1.36 | 1.51 | 1.30 | 1.43 | 5009.00 |
Mar 22, 2024 | 1.49 | 1.49 | 1.33 | 1.42 | 10874.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.60
Minimum
Nov 17 2023
16.02
Maximum
Aug 30 2021
2.751
Average
2.03
Median
Oct 10 2022
Price Benchmarks
Annexon Inc | 4.70 |
Longeveron Inc | 1.75 |
MiNK Therapeutics Inc | 0.9275 |
Adlai Nortye Ltd | 13.75 |
Telomir Pharmaceuticals Inc | 6.865 |
Price Related Metrics
Earnings Yield | -81.26% |
Market Cap | 20.96M |